From Ihub about ZLCS Zalicus valuation: Z160= $
Post# of 87
Posted On: 12/18/2012 10:19:21 AM
From Ihub about ZLCS
Zalicus valuation:
Z160= $1 billion
Z944= $1 billion
Partnering with Novartis= $500 million + Partnering with Novartis= $500 million + Prednisporin= $50 million + Exalgo= $200 Prednisporin= $50 million + Exalgo= $200 million.
Zalicus is strong undervalued.
PT $10 or more.
(0)
(0)EPIRUS Biopharmaceuticals, Inc. (EPRSQ) Stock Research Links
Scroll down for more posts ▼